Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis

NCT01149707

Conditions: Colitis, Colonic Diseases, Digestive System Diseases, +19 more
Locations: PurGenesis Investigational Site Jena, Germany

PurGenesis Investigational Site Köln-Merheim, Germany

PurGenesis Investigational Site Ludwigshafen, Germany

PurGenesis Investigational Site Minden, Germany

View Trial Details

Completed

Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy

NCT01314963

Conditions: Blood Protein Disorders, Breast Cancer, Breast Diseases, +18 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

NCT00921414

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Regional University Hospital Nantes, France

View Trial Details

Completed

Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma

NCT00574288

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Boston, Massachusetts, United States

Copenhagen Ø, Denmark

Vejle, Denmark

Amsterdam, Netherlands

View Trial Details

Completed

A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

NCT03097016

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, +14 more
Locations: DaVita Clinical Research Lakewood, Colorado, United States

DaVita Clinical Research Minneapolis, Minnesota, United States

View Trial Details

Completed

Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma

NCT01393717

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
Locations: City of Hope Medical Center Duarte, California, United States

Weill Medical College, Cornell University New York, United States

View Trial Details

Completed

Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma

NCT00884286

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Centre Hospitalier Lyon Sud Lyon, France

Hôpital Saint- Louis Paris, France

Institut Gustave Roussy Villejuif, France

Istituto di ematologia e oncologia medica "L. e. A. Seragnoli" Bologna, Italy

View Trial Details

Completed

Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome

NCT01171378

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Queen Elizabeth Hospital Birmingham Birmingham, United Kingdom

Royal Bournemouth Hospital Bournemouth, United Kingdom

Addenbrooke's Hospital Cambridge, United Kingdom

St James University Hospital Leeds, United Kingdom

View Trial Details

Completed

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

NCT00952237

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +24 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)

NCT01414855

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

cCare Encinitas, California, United States

University of Colorado Cancer Center Department of Hematology Aurora, Colorado, United States

Rocky Mountain Cancer Ctr - Denver (Williams) Denver, Colorado, United States

View all 38 locations

View Trial Details